Skip to main content

CORRECTION article

Front. Oncol., 07 April 2022
Sec. Cancer Immunity and Immunotherapy
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.895938

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

This article is a correction to:

  1. PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

    1. Read original article
Xiaoxiang Rong&#x;Xiaoxiang Rong1†Jinyu Lv&#x;Jinyu Lv1†Yantan Liu&#x;Yantan Liu1†Zhaojun Wang&#x;Zhaojun Wang1†Dongqiang ZengDongqiang Zeng1Yuedan LiYuedan Li1Shaowei LiShaowei Li1Jianhua WuJianhua Wu1Zheyu ShenZheyu Shen2Min ShiMin Shi1Wangjun LiaoWangjun Liao1Zhenzhen Wu*Zhenzhen Wu1*Chunlin Wang*Chunlin Wang1*
  • 1Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
  • 2School of Biomedical Engineering, Southern Medical University, Guangzhou, China

A Corrigendum on
PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

By Rong X, Lv J, Liu Y, Wang Z, Zeng D, Li Y, Li S, Wu J, Shen Z, Shi M, Liao W, Wu Z, Wang C. (2022) Front. Oncol. 11:802257. doi: 10.3389/fonc.2021.802257

There is an error in the Funding statement. The correct number for National Natural Science Foundation of China to Xiaoxiang Rong is No. 82073375.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Funding

This work was supported by the National Natural Science Foundation of China (No. 82073375 to XR, No. 81702398 to CW), China Postdoctoral Science Foundation (2019M663001 to XR), and the Science and Technology Planning Project of Guangzhou (No. 202102020532).

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: gastric cancer, PD-1, immune checkpoint blockade, tumor microenvironment, biomarker, cancer-associated fibroblasts

Citation: Rong X, Lv J, Liu Y, Wang Z, Zeng D, Li Y, Li S, Wu J, Shen Z, Shi M, Liao W, Wu Z and Wang C (2022) Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients. Front. Oncol. 12:895938. doi: 10.3389/fonc.2022.895938

Received: 14 March 2022; Accepted: 16 March 2022;
Published: 07 April 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Rong, Lv, Liu, Wang, Zeng, Li, Li, Wu, Shen, Shi, Liao, Wu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhenzhen Wu, wuzhenzhen1988@126.com; Chunlin Wang, wangchunl03@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.